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Health information systems (HISs) hold the promise to transform health care; however, their adoption is challenged.
We have developed the Clinical Adoption Meta-Model (CAMM) to help describe processes and possible challenges
with clinical adoption. The CAMM, developed through an action research study to evaluate a provincial HIS, is a
temporal model with four dimensions: availability, use, behaviour changes, and outcome changes. Seven CAMM
archetypes are described, illustrating classic trajectories of adoption of HISs over time. Each archetype includes an
example from the literature. The CAMM and its archetypes can support HIS implementers, evaluators, learners, and
researchers.
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Health information systems (HISs) have been described
as one of the key tools to transform and improve quality
of our healthcare systems [1,2]. However, the promise of
these transformative tools has not been consistently seen
[3-5] and meaningful adoption in many jurisdictions re-
mains low [6,7]. The deployment of HISs has met with a
wide variability in outcomes from benchmark successes
that lead to transformations in care [8] to never being
deployed in a clinical setting. Adoption of HISs has been
a significant and increasing concern in healthcare [9]
and an important problem to be addressed [10]. Adop-
tion needs to be better described and understood with
approaches that are accessible to people planning and
implementing these systems.
In this paper we present the Clinical Adoption Meta-
Model (CAMM). The CAMM has been developed to
describe HIS adoption over time. First, we provide back-
ground on adoption models. Then we present the CAMM,
followed by seven CAMM archetypes that illustrate classic
adoption patterns. We finish this paper with a discussion* Correspondence: morgan@leadlab.ca
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reproduction in any medium, provided the oron how the CAMM and its archetypes can support imple-
menters, evaluators, learners, and researchers.Adoption models
Adoption is the process that “involves the multitude of
activities, decisions, and evaluations that encompass the
broad effort to successfully integrate an innovation into
the functional structure of a formal organization” [11]
(p. 5). An adoption model provides a simplified and lim-
ited explanation of the complex process of integration
over time. For information systems, this involves the
complex sociotechnical aspects that occur over time
from initial deployment through to integration into
practice [12]. For this paper, we will use the term adop-
tion model to describe models related to the activities of
integration into practice post deployment. Adoption
models, while they can be quite different, should have a
number of common features to be considered an adop-
tion model. These are: (a) they describe a number of di-
mensions related to adoption; (b) they are designed for a
specific audience; (c) they allow for variability in assess-
ment [13].
Outside of healthcare, there are many general adop-
tion models, such as: Technology Acceptance Model
(TAM) [14,15] and the TAM 2 [16], Unified Theory of
Acceptance and Use of Technology (UTAUT) [17], ISl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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the Concerns Based Adoption Model (CBAM) [11]. Diffu-
sion of innovation [19,20] describes the spread (adoption)
of an innovation (idea, process, technology) through chan-
nels within a social system. Adoption models such as the
Capability Maturity Model Integration (CMMI) focus on
maturity of the processes of the team managing the devel-
opment [21,22]. Models like the CMMI are important for
HIS development/configuration, but for clinical adoption,
we are more interested in how the tools integrate into
clinical practice.
Adoption models in healthcare
Several existing adoption models have been applied to
healthcare and to healthcare technology. An extensive re-
view of diffusion of innovation in healthcare [23] recom-
mends we seek to better understand why innovations are
rejected (discontinued) once adopted. The CBAM has
been applied to telemedicine [24]. TAM has been used in
over 20 studies in healthcare to inform use acceptance
and adoption [25]. TAM2 has also been applied [26].
Adoption models have been developed specific to
healthcare. The Fit between Individuals, Task and
Technology (FITT) framework highlights that adoption
depends on alignment of three factors: technology, indi-
vidual and task [9]. HOT-fit was used to understand crit-
ical adoption factors for HISs [27]. The Clinical Adoption
Framework [28] contextualizes the IS Success Model [12]
into healthcare and extends it by providing meso and
macro level factors that can influence the adoption of
clinical information systems. The Design-Reality Gap
Model from Heeks [10] outlines seven dimensions from
information to management systems and structures re-
lated to HIS failure.
Adoption models have been developed for specific do-
mains within healthcare. HIMSS Analytics provides three
EMR adoption models (EMRAM), one each for US
hospital based HISs, Canadian hospital HISs, and for US
Ambulatory EMRs [29,30]. Each of the three EMRAMs
provide an eight-point (0–7) scale of adoption of featuresFigure 1 The Clinical Adoption Meta-Model with its four dimensions.of the HIS. Diagnostic imaging have models to describe
capability for collaborative jurisdictional infrastructure
maturity [31]. The PACS maturity model [32,33] describes
the process maturity of hospital based PACS systems in
terms of functionality and integration into practice work-
flow. The EMR (Electronic Medical Records) Adoption
Model [34] provides an adoption assessment tool that
breaks down office-based EMR adoption into 10 func-
tional areas.
What appears missing from these models is a contex-
tualized adoption model that is (a) generic to health, but
(b) is sufficiently contextualized as to be accessible to
key stakeholder audiences such as clinicians and admin-
istrators that (c) ties together HIS adoption and clinical
benefit over time to guide expectations of adoption over
time. Next, we present our Clinical Adoption Meta-Model
(CAMM) that attempts to do that.
Clinical Adoption Meta-Model (CAMM)
CAMM development and evaluation
The CAMM (Figure 1) was developed at the eHealth
Observatory (ehealth.uvic.ca) to address needs in an on-
going action research and evaluation project that is
assisting the benefits evaluation of the deployment of a
provincial HIS in Canada. The CAMM was developed to
address the need to situate the evaluation throughout
the adoption process, providing early and ongoing evalu-
ation. The action research project has moved through
three phases: assessing the initial evaluation plan, pro-
vided a revised evaluation approach, and implementing
the revised evaluation while the HIS was adopted. The
project is currently in the implementation phase.
Through multiple stakeholder meetings during the
first two phases, it became clear that a common under-
standing of HIS adoption over time was needed. Several
of the existing models that were considered did not
resonate with stakeholders. There were three key gaps:
1. Some models did not fit the deployment/time focus of
the stakeholders. 2. They were too complex and thus not
engaging. 3. They were too general and did not help(see http://ehealth.uvic.ca/methodology/models/CMM.php).
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stakeholders was to have an approach to understanding
how to assess their HIS program benefits over time, so
that realistic expectations could be set while still ensur-
ing metrics could be measured in a timely manner to
show progress. The CAMM grew out of reflections by
the research team between iterations in this ongoing ac-
tion research study.
Evaluation of CAMM has been primarily through the
action research project. The CAMM was used to assess
the initial evaluation plan, highlighting gaps to stake-
holders. It was then subsequently used to co-develop a
new evaluation plan that addressed the life cycle of adop-
tion of a provincial HIS. It is now being used through
phases of adoption evaluation.
The CAMM has since been used as a discussion and
planning tool used with IT leadership, clinicians, IT im-
plementers outside the above mentioned project with
other stakeholders who are planning implementations of
HIS and also with students who are learning about HIS
adoption.
CAMM is a time dependent meta-model, with four di-
mensions related to post-deployment adoption: availabil-
ity, use, clinical behaviour, and clinical outcomes. The
dimensions are themselves dependent on each other: HIS
availability is required before use can occur, use is needed
to attribute changes in clinical/health behaviours to the
HIS, and behavior changes can result in clinical outcomes
change. Each dimension in the CAMM can have one or
more aspects, which are dependent on the scope of the
HIS implementation being considered. The dimensions
and their aspects are described in more detail below. The
Y-axis measures indicators for each dimension, the spe-
cifics of which necessarily vary from HIS to HIS.
The CAMM is designed to be generic such that it
could be applied to a hospital information system de-
ployment, an office based EMR, a personal health rec-
ord, or a health app on smart phones. It could support
thinking around deployment of a full HIS, a specific fea-
ture, to a new group of users, or it could be used to con-
sider regional or jurisdictional adoption.
Dimension 1. availability
The first dimension, availability, is defined as ability for
the end users to interact with an HIS. Availability in-
cludes three aspects: user access; system availability; and
availability of content in the HIS. User access considers
the ability for intended users to access the system (i.e.
they have accounts, have been trained). System availabil-
ity considers how available the HIS is to the intended
users (e.g. uptime, physical availability of terminals, re-
mote login capabilities, mobile applications). Content
availability considers depth and breadth of content that
is available in the HIS. This will vary, depending on theHIS, such as various types of patient data or knowledge
content.Dimension 2. system use
The CAMM’s second dimension, use, is defined as the
interactions with the HIS by intended end-users. There
are two aspects to use: use of the system and user ex-
perience of the system. Use refers to actual use of the
application, such as: logins, time using the system, fea-
tures used. The user experience aspect is a subjective ex-
perience of use that combines the user’s internal state,
the information system (in this case the HIS), and the
context in which the interactions occur [35]. User ex-
perience is broader than user satisfaction or usability.
Demonstrated use of the HIS is required in order to
make any assumptions correlating the HIS to changes in
clinical behaviours or clinical outcomes.Dimension 3. clinical/health behaviour
The CAMM’s third dimension, clinical/health behaviour,
is defined as meaningful adaptation of clinical work-
flows or health behaviours that are facilitated by the
HIS. These can align with clinical/business goals or be
unintended changes in behaviour of adopting the HIS.
Clinical behaviours differ from system use in that the
users are incorporating information and functions pro-
vided by the information system into activities not dir-
ectly related to the use of the system. Aspects of clinical
behaviour change include general capacity and specific
clinical activity changes. Capacity describes changes in
the overall ability of the healthcare organization, which
can be impacted positively or negatively by use of the
HIS. Clinical activities are those specific behaviours that
are impacted by HIS features. Clinical/health behaviours
could be seen in providers and patients.Dimension 4. clinical outcomes
The final dimension, clinical outcomes, is defined as the
impacts attributable to the adoption of the HIS. There are
five aspects to clinical outcomes that can be considered: pa-
tient level outcomes, provider level outcomes, organization
level outcomes, population level outcomes, and cost out-
comes. Measures of outcomes can be early or late. Early or
surrogate outcomes are often needed in cases where it is
not possible to wait for final or later outcomes.
Combined, these four dimensions make up an adoption
trajectory from HIS deployment to changes in clinical out-
comes. Time, which links all dimensions together in this
model, could be considered a fifth dimension. The dimen-
sions and aspects are summarized in Table 1 along with
example indicators. Next, we present seven CAMM arche-
types that show different adoption trajectories.
Table 1 Dimensions and Aspects of the CAMM, each dimension can have several more detailed aspects that can be
considered
Dimension Aspects Example indicators
1 – Availability - System availability - Percentage of uptime of an EMR
- User access - Number of users with accounts for a Personal Health Record.
- Content availability - Months of dispensing data for a dispensing record.
2 – System use - Use - Number of log ins/user/month
- User experience - Survey of user experience.
3 – Clinical behaviour - General capacity - Number of patients seen per day in office.
- Specific behaviours - Rates of blood pressure screening
4 – Clinical outcomes - Patient outcomes - Change in blood pressure
- Provider outcomes
- Organizational outcomes - Nosocomial infection rates
- Population outcomes - Rates of obesity
- Cost outcomes - Changes in relative cost curves for an organization
Indicators can be developed based on the aspects for each dimension, as relevant to the particular HIS and the context of the adoption.
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The following seven archetypes were developed to describe
typical adoption trajectories for clinical information sys-
tems. Not all of these archetypes lead to success. Many
HIS implementations fail in some way [36] and thus, the
archetypes capture a range of results from successful adop-
tions to aborted adoptions. For each archetype, we de-
scribe the adoption pattern, highlight some potential
implications, and provide an exemplar study from the lit-
erature that illustrates the archetype. The example studies
were selected from the corpus of eHealth studies from two
recent systematic reviews [4,5]. Archetypes may be useful
in teaching on HIS adoption, when considering success or
challenges of a specific HIS adoption, or when planning
implementation and evaluations with stakeholders.
The prototypical adoption archetypes are:
1. No Deployment.
2. Low Adoption.
3. Adoption without Benefit (behaviour and outcome).
4. Behaviour Change without Outcome Benefit.
5. Adoption with Outcome Benefits.
6. Adoption with Harm.
7. Benefit without Use.
No deployment archetype
This archetype describes an HIS that is not released to
its users. There could be many reasons that this occurs,
such as: the HIS is not completed, a flaw prevents de-
ployment, or strategic changes prevent implementation.
In this model, all four curves are flat (not shown).
The decision support application for primary care,
EGADSS (Evidence-based Guidelines And Decision Support
System) [37-39], is an example of this archetype. It was
developed as an EMR component that connected to anEMR to provide CDSS reminders. However, it was not de-
ployed to end users due to changes in funding and lack of
adoption of the standards used in the interface between
the EGADSS product and the primary care EMRs.
Low adoption archetype
In this archetype (Figure 2) we see availability of the sys-
tem increase but use is not sustained. No behaviour
changes or outcome benefits are seen that can be attrib-
uted to the HIS. This can happen where HIS use is vol-
untary and it does not fit the clinical environment. Users
may trial it after being given access (thus the rise in use
in the diagram), but when value is not perceived or it is
too cumbersome to use, then use diminishes or stops.
An example is the 2-year pre/post cluster randomized
controlled trial by Eccles et al. [40] to evaluate the use of
computerized guidelines in managing adult patients with
asthma and angina in primary care. Sixty general practices
with EMRs in northeast England took part in the study
where half adopted a guideline decision support software
module. At the end of the 1-year intervention, the authors
found the module had no significant effect on consult-
ation rates; process of care measures or patient reported
outcomes. On closer examination, the system usage log
files revealed little to no usage of the module. The authors
concluded that the low adoption was likely due to the
guidelines not being consistent with the practice norms,
the software not integrated into the clinical workflow, and
insufficient user training. Thus lack of use precluded it
having impacts on behaviour or outcomes.
Adoption without benefits archetype
In this archetype (Figure 3) we see an HIS that is avail-
able and is used (e.g. clinicians, patients) but the ex-
pected benefits, behaviours and outcomes, do not occur.
Figure 2 Low Adoption Archetype. Availability increases and there may be a surge of use, but use tapers off and the project is halted.
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a current workflow. Benefits may not occur for several
reasons, such as: an existing process is simply replicated,
changes are not evidence-based, end-users chose not to
incorporate the features, they are constrained by cap-
acity, good practice was already present (i.e. a ceiling
effect is reached for the indicators), or the duration of
evaluation is not sufficient to see changes.
An example is the 1-year randomized controlled trial
by Tierney et al. [41] on the effects of computerized
guidelines in managing heart disease. 706 outpatients
with heart disease were followed for 1 year where they
made 3,419 primary care visits and were eligible for
2,609 cardiac care suggestions. During the study, 201
physicians in the intervention group had cardiac care
suggestions displayed based on data they entered into
the EMR in the encounter. The study showed no meas-
urable effects on physicians’ adherence to care sugges-
tions, health care utilization and costs, and patients’
medication adherence, satisfaction with care, and quality
of life. The authors reported that physicians felt the
guidelines provided useful information, but were con-
straining their management of individual patients.Figure 3 Adoption without benefits archetype. Availability and use incr
outcomes are not seen.Although the HIS was used, clinical behaviours or out-
comes were not influenced.
Behaviour change without outcome benefits archetype
This archetype (Figure 4) highlights a key challenge of
HIS implementations: even though the system is being
used and an intended behaviour change occurs, expected
outcomes are not realized. This can occur for a number
of reasons: outcomes are already good (i.e. a ceiling has
been reached); a longer time is required to see the clin-
ical outcome; the behaviours supported are not linked to
the outcome. The last one suggests that the intervention
enabled by the HIS is not evidence-based or not appro-
priate for the setting in which it was deployed.
An example is the interrupted time series study by van
Doormaal et al. [42] on the effect of electronic prescrib-
ing on medication errors and preventable adverse drug
events in two medical wards at a university medical
centre in the Netherlands. Medication orders, errors,
and adverse events were tracked for 5 months each be-
fore and after the implementation of a computerized
provider order entry system with decision support for
drug-drug interactions, overdosing, and allergy alerts.ease has planned, but the corresponding behaviour changes and
Figure 4 Behaviour change without outcome benefits archetype. Behaviours change, likely through availability and use of the HIS, but
clinical outcomes are not seen.
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verse drug events from 1,195 in patients were compared
for differences. The system led to a significant reduction
in medication orders with one or more medication er-
rors (behaviour change) but not in preventable adverse
events (no outcome change). The authors concluded the
system lacked advanced decision support rules in thera-
peutic error detection and a relevant hospital formulary
database in order to reduce adverse events.
Adoption with benefit archetype
This archetype (see Figure 1) is the archetype that HIS
implementers expect to see. There is a correlation be-
tween HIS availability, use, behaviour, and the expected
outcomes. See the initial description of the CAMM
above.
An example is the 5-year retrospective time series
study by Cook et al. [43] on the effect of an electronic
medical record on antimicrobial use and nosocomial in-
fections at a tertiary care hospital in the United States.Figure 5 Benefit without use archetype. Adoption does not occur as ex
attributed to the HIS, but a confounder.In this study, the pattern of antimicrobial drug use,
number of medical charts reviewed, number of anti-
microbial recommendations made and accepted, and
rates of Clostridium difficile and methicillin-resistant
Staphylococcus aureus infections were assessed. Data
was reviewed for 10 quarters before and 10 quarters
after implementing the electronic medical record. Re-
sults were compared for differences. The study found
significant increase in the number of charts reviewed
(use), antimicrobial recommendations made and ac-
cepted after implementing the system (behaviour). There
were decreased use of 41 commonly used antibacterial
agents and reduced rates of nosocomial infections dur-
ing the study period (early outcome). This retrospective
study showed a correlation between HIS feature in use,
clinical behaviour, and outcomes.
Benefit without use archetype
In this archetype (Figure 5), we see the expected im-
provements in behaviour and outcomes; however, thesepected, but still a clinical benefit is measured. This should not be
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the HIS). In this archetype, one or more confounding in-
terventions have occurred to achieve the expected im-
provements. In complex environments (e.g. healthcare)
multiple interventions can often be occurring simultan-
eously, making the assessment of actual impact of HISs
challenging.
Finding a published example of this archetype proved
challenging. Perhaps this is because HIS evaluations are
often focused on the intervention. Several studies in our
corpus may fit this archetype, but they did not explicitly
measure use. This was also seen in Dorr’s systematic re-
view of HIS use in improving chronic disease manage-
ment: “lack of use of otherwise successful components
in standard EHR implementations should be quantified
and barriers for use identified” [44] (p.162).
Adoption with harm archetype
This archetype (Figure 6) illustrates that use of an HIS
can lead to negative behaviours and/or outcomes. This is
the opposite of the intention of HIS adoption and is one
to avoid. Harms should be looked for during adoption of
an HIS as they can occur in unexpected ways. These are
unintended consequences of adoption. The expected
outcome may/may not occur, but other aspects of care
could change, resulting in unexpected harm.
An example is the comparison of diabetes care in pri-
mary care practices by Crosson et al. [45] where a cross
sectional analysis of 50 primary care practices was com-
pleted examining quality of diabetes care through a ran-
dom sampled chart audit against process guideline and
outcome targets. 37 practices were paper based and 13
used EMRs. Multivariate analysis showed that EMR
using practices were less likely to be following diabetes
care process guidelines (clinical behaviour) and had
worse intermediate outcomes (A1c, cholesterol, and
blood pressure outcomes). Unfortunately, the authors
did not collect duration of EMR use or any otherFigure 6 Adoption with harm archetype. Unintended consequence(s) o
measured harm.characteristics of EMR adoption (e.g. type of EMR, fea-
tures available, features used) that could be used to bet-
ter explain the findings.
Discussion
Adoption rates for HISs are variable and there are range
of reasons for low adoption rates [46,47]. The CAMM
was developed from a need to provide a focused descrip-
tion of how HIS benefits could be achieved over time
(or not) and to fill a perceived gap in the literature.
Highlighted in Table 2, the CAMM differs from many
generic adoption models, such as the diffusion of
innovation, TAM, and UTAUT, as it is contextualized to
the clinical domain. And, unlike several clinical adoption
models, such as the PACS maturity model [32,33], the
HIMSS EMRAMs [29,30], or EMR Adoption Model
[34], the CAMM is less focused on purely feature adop-
tion and is also is generic enough to be applied to a
range of clinical adoption contexts and clinical informa-
tion systems from personal health records to hospital
systems. CAMM is explicitly focused on the measurable
outcomes that are linked to integration of IT into clin-
ical practice over time, unlike the FITT [9] or Design-
Reality Gap model [10]. Thus, the CAMM fills a gap in
healthcare adoption models. The CAMM meets the
Lahrmann criteria for an adoption model [13,48]: first,
the CAMM has multiple dimensions (they describe clin-
ical adoption over time); second, the CAMM allows for
variability in assessment (methods are not specified);
third, the CAMM is developed for specific audiences.
Several audiences were considered as the CAMM was
developed: implementers, evaluators, learners, and re-
searchers. How the CAMM can support each of these
audiences is described below.
Implementers
The CAMM can support implementers as they deploy
an HIS (or HIS feature). In planning, they can use theccur after the deployment and adoption of the HIS resulting in a
Table 2 Comparison of the CAMM with other adoption models, CAMM is most focused on linking early adoption
(e.g. availability and use) to later adoption benefits in the context of healthcare
Model Time dependent Contextualized to health Applicable to
a range of HISs
Links adoption
with clinical benefit
TAM No No Yes No
UTAUT No No Yes No
Diffusion of innovation Yes, explicit No Yes No, on diffusion
IS success Implicit Is through Canada Health
Infoway BE Framework and
Clinical Adoption Framework
Yes Yes, on net benefits.
FITT No No Yes No, focused on fit of
individuals, tasks and IT.
HIMSS EMRAMs Implicit (scores should
increase over time)
Yes, to EMRs Several EMRAMs for different EMRs Focused on adoption
of EMR features.
PACS maturity model Implicit Yes, to PACS No, PACS specific Focused on PACS features
and integration, not benefit
EMR adoption model No Yes, to EMRs No, office EMR only. No, focused on EMR use.
Design-reality gap model No Yes, developed in hospital Yes No, focused on gaps.
The CAMM Yes, explicit Yes Yes Yes
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expected behaviour changes, use, and availability, thus
helping to describe the functionality and deployment
needs through a causal chain. For example, if a diabetes
chronic disease management tool is being deployed, the
desired outcomes may be related to mortality and hos-
pital use and, more proximally, A1c and other surrogate
markers. The implementation team could consider how
to structure training related to the tool use and to focus
on behaviours related to reaching those goals (e.g. pa-
tient recalls). Availability could be structured to ensure
the proper clinicians have access to the tool at appropri-
ate locations and use could be promoted with those key
groups. The CAMM can also help set the expectations
of management, describing the processes required to
reach the desired outcomes and why these are not seen
immediately.
Evaluators
If the CAMM is used as a model to support HIS adop-
tion evaluation, metrics assessing each of the four di-
mensions should be considered and be conceptually
linked to each other. The further from go live, the
harder it is to attribute observed changes directly to the
HIS. Thus a tight linkage and clear temporal relation-
ships between availability, use, behaviour and outcomes
will strengthen attribution. Also, the CAMM highlights
the importance of evaluating all four dimensions to en-
sure “Benefit without Use” is not occurring. CAMM
does not specify evaluation methods; however, the
CAMM can help theoretically link multi-methods across
dimensions. The CAMM was especially useful in the ac-
tion research study in which it was developed to bothset expectations and to determine appropriate dimen-
sions to measure that would align with stakeholder
needs. Specifically, the need to provide progress reports
on the program at specific times. The CAMM helped fa-
cilitate a discussion on what would be reasonable to
evaluate for each reporting period. Through using the
CAMM, evolving metric sets were considered that eval-
uated access, use, behaviour and ultimately outcomes
over time.
Learners
Health informatics students and clinicians learning
about HIS adoption can apply the CAMM as a frame-
work for understanding adoption and impact of HISs
over time. The CAMM and archetypes can be used with
learners as a tool to describe, compare, and discuss im-
plementation case studies.
Researchers
The CAMM provides a framework to consider the
stages of integration into practice that could be helpful
in aiding researchers design studies on adoption. It can
help researchers better understand challenged imple-
mentations. We have provided some examples in this
paper. The CAMM provides a common model to com-
pare adoption of HISs (or features) for meta-analyses.
Limitations and future work
There are several areas of future work for CAMM. The
CAMM was developed through an action research pro-
ject and, while it has been informally used in a number
of settings since, a more formal evaluation is needed.
Specific timeframe for adoption is not specified in the
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stand the expected timing of each curve for various kinds
of HIS adoptions: office based EMR, hospital information
systems, and personal health records. Better understand-
ing the frequency of “Benefit without Use” is needed [44].
There is a need to consider HISs as complex systems
[9,49] and the CAMM can support the assessment by pro-
viding a time based model against which one can assess
complex interventions. CAMM intentionally focused on
the direct aspects of adoption (i.e. the four dimensions).
Indirect aspects of adoption were explicitly out of scope as
this model was developed. Indirect aspects, however, will
impact adoption in a complex system. This is a limitation
and area for future development. The CAMM, while con-
textualized to healthcare (e.g. clinical outcomes), could
have applications in other domains (e.g. in education one
could consider learning behaviours and learning outcomes
for learning tools).
Conclusion
The CAMM is presented to address a gap in the litera-
ture that was highlighted through an action research and
evaluation project. It is an adoption meta-model that is
focused on the temporal dimension of clinical adoption.
It is general enough to be applied in multiple settings
with multiple HISs from personal health records to hos-
pital information systems. It is designed to be accessible
by a range of audiences from implementers to learners.
The seven CAMM archetypes provided are helpful in
comparing varying levels of successful adoption. It high-
lights the importance of measuring multiple aspects of
adoption over time to ensure that attribution of benefit
can be realistically attributed to the use of HISs. As a
new adoption meta-model, the CAMM needs additional
application with further research.
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